Image of A Blood Test for the Early Detection of Lung Cancer
On Demand

A Blood Test for the Early Detection of Lung Cancer

Total Credits: .75 including .75 AOA Category 2-A CME Credit

Average Rating:
MAOPS July 2020 - White Package
Cancer |  Continuing Education |  Family Medicine |  MAOPS |  Medical Education |  Oncology
Laura Peek, PhD,
47 Minutes
Never expires.


This lecture by Laura Peek, Ph.D. offers information and tools regarding blood testing for the early detection of lunch cancer.

Learning Objectives:

  • Describe EarlyCDT-Lung, a blood test to aid in the risk assessment and early detection of lung cancer. 
  • Explain the benefits and limitations of EarlyCDT-Lung testing in the context of patient factors and test performance.
  • Explain how EarlyCDT-Lung complements current recommended guidelines for lung cancer screening.




Laura Peek, PhD's Profile

Laura Peek, PhD Related seminars and products: 1

Laura Peek, PhD, is the Principal Scientist and Assistant Laboratory Director for Oncimmune USA which is located in De Soto, Kansas.  She attended Baker University in Kansas for her undergraduate degree in Chemistry.  She then completed a Master’s degree and a PhD in Pharmaceutical Chemistry at the University of Kansas in Lawrence, Kansas.  She worked as a post-doctoral researcher prior to joining Oncimmune.  Dr. Peek serves her profession as a Board member of the Society of Self Fellows at KU and as a Baker University Mentor. She has identified that she has an affiliation/financial interest in Oncimmune, the maker of EarlyCDT-Lung, a product she will talk about in her presentation today.  Oncimmune is sponsoring this presentation. 


Dr. Peek discloses that she has no relevant financial relationships with any organizaiton producing, marketing, reselling or distributing health care goods or services consumed by, or used on, patients relative to the content of this this presentaion.  


Please wait ...

Back to Top